This remained significant after adjustment for age, sex, Model for End-Stage Liver Disease (MELD), serum-sodium, serum-cholinesterase, diabetes, body mass index and norfloxacin (HR = 0.59; p = 0.02) in the multivariable competing risk model. This evidence concerns the gene BCHE and diabetes mellitus.